Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland

BACKGROUND: This study aimed to undertake an analysis of ten years of real-world evidence (RWE) on overall survival (OS) following treatment of advanced gastrointestinal stromal tumor (GIST) with imatinib, sunitinib, and sorafenib using data from the Polish National Health Fund. MATERIAL/METHODS: Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Brzozowska, Melania, Wierzba, Waldemar, Szafraniec-Buryło, Sylwia, Czech, Marcin, Połowinczak-Przybyłek, Joanna, Potemski, Piotr, Śliwczyński, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543874/
https://www.ncbi.nlm.nih.gov/pubmed/31121600
http://dx.doi.org/10.12659/MSM.914517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543874/
https://www.ncbi.nlm.nih.gov/pubmed/31121600
http://dx.doi.org/10.12659/MSM.914517

Ejemplares similares